Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Remission of bile acid malabsorption symptoms following treatment with the glucagon-like peptide 1 receptor agonist liraglutide

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Validation and update of the Lémann index to measure cumulative structural bowel damage in Crohn's disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B cell-Based Vaccine Development

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Crohn's Disease With Progressive Renal Impairment

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. Exendin(9-39)NH2 - recommendations for clinical use based on a systematic literature review

    Research output: Contribution to journalReviewResearchpeer-review

  2. MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatin

    Research output: Contribution to journalReviewResearchpeer-review

  3. Hepatic microbiome in healthy lean and obese humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pancreatic polypeptide: A potential biomarker of glucose-dependent insulinotropic polypeptide receptor activation in vivo

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalGastroenterology
Volume157
Issue number2
Pages (from-to)569-571
Number of pages3
ISSN0016-5085
DOIs
Publication statusPublished - 1 Aug 2019

    Research areas

  • Aged, Bile Acids and Salts/metabolism, Diabetes Mellitus, Type 2/complications, Female, Glucagon-Like Peptide-1 Receptor/antagonists & inhibitors, Humans, Liraglutide/pharmacology, Malabsorption Syndromes/drug therapy, Male, Middle Aged, Overweight/complications, Remission Induction/methods, Treatment Outcome

ID: 56957683